ZNF444
Zinc finger protein 444
Also known as: EZF2, FLJ11137, ZN444_HUMAN, ZSCAN17
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N0Y2
- Gene
- ZNF444
- Ensembl
- ENSG00000167685
- Chromosome
- 19
- Canonical length
- 327 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
This gene encodes a zinc finger protein which activates transcription of a scavenger receptor gene involved in the degradation of acetylated low density lipoprotein (Ac-LDL) (PMID: 11978792). This gene is located in a cluster of zinc finger genes on chromosome 19 at q13.4. A pseudogene of this gene is located on chromosome 15. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
327 residues, UniProt reviewed canonical sequence.
>Q8N0Y2|ZNF444
1 MEVAVPVKQE AEGLALDSPW HRFRRFHLGD APGPREALGL LRALCRDWLR PEVHTKEQML
61 ELLVLEQFLS ALPADTQAWV CSRQPQSGEE AVALLEELWG PAASPDGSSA TRVPQDVTQG
121 PGATGGKEDS GMIPLAGTAP GAEGPAPGDS QAVRPYKQEP SSPPLAPGLP AFLAAPGTTS
181 CPECGKTSLK PAHLLRHRQS HSGEKPHACP ECGKAFRRKE HLRRHRDTHP GSPGSPGPAL
241 RPLPAREKPH ACCECGKTFY WREHLVRHRK THSGARPFAC WECGKGFGRR EHVLRHQRIH
301 GRAAASAQGA VAPGPDGGGP FPPWPLGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF444 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 64 nTPM
Expression across tissuesHPA
Tissue
- liver: 64 nTPM
- pancreas: 45 nTPM
- cerebral cortex: 40 nTPM
- basal ganglia: 36 nTPM
- cerebellum: 35 nTPM
- amygdala: 35 nTPM
Single-cell type
- late spermatids: 62 nCPM
- respiratory ciliated cells: 52 nCPM
- hepatocytes: 50 nCPM
- tuft cells: 46 nCPM
- pituitary stem cells: 45 nCPM
- alveolar cells type 2: 45 nCPM
Immune cell
- memory CD4 T-cell: 4 nTPM
- memory CD8 T-cell: 4 nTPM
- naive CD4 T-cell: 4 nTPM
- T-reg: 2.9 nTPM
- naive CD8 T-cell: 2.7 nTPM
- MAIT T-cell: 2.5 nTPM
Brain region
- medulla oblongata: 62 nTPM
- amygdala: 52 nTPM
- midbrain: 50 nTPM
- thalamus: 50 nTPM
- cerebral cortex: 50 nTPM
- white matter: 47 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.45
- gnomAD pLI
- 0.87
- gnomAD missense Z
- 1.8
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF444 as an antibody target. Whether an autoantibody or antibody against ZNF444 could matter depends on whether native ZNF444 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF444 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF444 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...